At the recent IMPAKT Breast Cancer Conference, 2 – 4th May, Brussels, ecancer´s Peter Goodwin talks to Ana Vivancos about her pioneering research in cancer genomics and work contributing to improved phase I clinical studies and best therapies for patients.
Related Posts
VHIO Meet the Editors with AACR´s Cancer Discovery – the new "kid on the block"
Taking place on Monday 24 February 2014, 09:15 – 10:30, we are delighted to advance that Executive Editor of Cancer…
14 Nov 2013
Warm reception for Barcelona Clinical Trials Platform (BCTP) at Farmaindustria
Source: Biocat Yesterday, 27 June 2015, the Catalan Ministry of Health and Biocat presented their joint initiative Barcelona Clinical Trials…
28 May 2015
Therapeutic targets for cancer
Arkaitz Carracedo, from the Harvard Medical School, gives a lecture on the latest developments on potential therapy for cancer
07 Sep 2010
Unmasking the molecular mechanisms driving resistance to targeted therapy against metastatic non-small cell lung cancer
Published as an open access article last week in the flagship journal of the European Society of Medical Oncology (ESMO),…
27 Jul 2017
The promise of an active surveillance strategy in patients with metastatic renal cancer
VHIO co-collaborates in a prospective, phase II clinical trial studying patients with metastatic renal-cell carcinoma Findings evidenced active surveillance as…
13 Sep 2016
VHIO´s Josep Tabernero awarded the Josep Trueta Medal for his outstanding contribution to advancing healthcare
Officially announced yesterday, the Government of the Generalitat of Catalonia has revealed the thirteen recipients of the Josep Trueta Medal…
14 Dec 2016
VHIO´s Enriqueta Felip: recipient of the recently launched ESMO Women for Oncology Award
Source: The European Society for Medical Oncology (ESMO) Lugano, Switzerland, 27 August 2015 — The European Society for Medical Oncology…
01 Sep 2015
VHIO´s next Meet the Editors with Nature Medicine
Nature Medicine´s Senior Editor, Vicotria Aranda will come to VHIO Monday 17 September 2012 to deliver the 4th in the prestigious series of VHIO Meet the Editors talks.
28 Jun 2012
VHIO on the ground and delivering data at San Antonio Breast Cancer Symposium 2016
Now in its 39th annual edition, the San Antonio Breast Cancer Symposium (SABCS) is the world´s largest, multidisciplinary breast cancer…
08 Dec 2016
Date in the diary with Nature Reviews Cancer 29 June 15:00h – 16:15h
Taking place on Monday 29 June 2015, 15:00 – 16:15, we are delighted to announce that Senior Editor of Nature Reviews Cancer,…
15 Jun 2015
Liquid biopsy of cerebrospinal fluid for less invasive, more effective ´policing´ of brain tumors
VHIO leads research proposing cerebrospinal fluid (CSF) as liquid biopsy for the early diagnosis, prognosis, therapeutic management and tracking of…
10 Nov 2015
FDA Allows WIN Consortium to Proceed with Targeted Tri-Therapy Clinical Trial in First Line Treatment of Metastatic Non Small Cell Lung Cancer
Source: WIN Consortium VILLEJUIF, France–(BUSINESS WIRE)– WIN Consortium (WIN) received the US Food and Drug Administration (FDA)’s approval to start…
09 Aug 2017
Joan Seoane awarded ERC Proof of Concept Grant to bring ´blue sky´research towards market
The European Research Council (ERC) has awarded Joan Seoane, Director of Translational Research at the Vall d’Hebron Institute of Oncology…
24 Feb 2013
LIF, a gene involved in the proliferation of tumour stem cells
The Vall d’Hebron Institute of Oncology (VHIO) has published a new study describing a new molecular mechanism that regulates the renewal of the glioma stem cells. The findings represent an important advancement in the research centred on one of the most aggressive brain tumours, the glioblastoma multiforme
07 Sep 2010
